Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.03.12.711259

A newly identified detoxification system protects uropathogenic Escherichia coli from reactive chlorine species

Abstract

Neutrophils eliminate invading pathogens through the production of reactive oxygen and chlorine species (ROS/RCS), with hypochlorous acid (HOCl) representing the most abundant and bactericidal oxidant produced in this process. Compared to bacterial defenses against ROS, which are well studied, little is known about how pathogens respond to and counter RCS, including HOCl. Here, we identify and mechanistically characterize RcrB, a protein of the uncharacterized DUF417 protein family, for which no role in oxidative stress defense has been described yet. We report a previously unrecognized role as an RCS detoxification system that confers high-level resistance to uropathogenic Escherichia coli (UPEC). We show that RcrB is an inner membrane protein and strongly induced during RCS exposure and phagocytosis. Loss of RcrB results in profound HOCl hypersensitivity, accompanied by elevated macromolecular damage and severe metabolic perturbations, establishing RcrB as a central determinant of UPECs RCS stress resistance. Heterologous expression of RcrB in HOCl-sensitive intestinal E. coli strains is sufficient to restore resistance but requires functional glutathione biosynthesis. Quantitative HOCl trapping assays demonstrate that RcrB expression protects the bacterial population by significantly reducing extracellular HOCl, indicating active chemical quenching rather than passive membrane protection. Structure-function analysis of RcrB confirms this conclusion and demonstrate that conserved, redox-active amino acids facing the periplasm are essential for its detoxification activity. In summary, our study reveals a hitherto unknown bacterial strategy for mitigating RCS and reveal a distinct mechanism by which UPEC may survive the mammalian host defense. Significance StatementDuring infection, human immune cells such as neutrophils kill bacteria by releasing powerful oxidants, including hypochlorous acid (HOCl), the active ingredient of household bleach. How pathogenic bacteria survive this chemical attack is still poorly understood. This study identifies a membrane protein in uropathogenic Escherichia coli as a key defense factor that neutralizes HOCl before it can damage the cell. RcrB acts at the bacterial cell envelope, where it detoxifies HOCl in a glutathione-dependent manner to maintain a balanced redox homeostasis and cellular integrity, thereby even protect neighboring bacteria. These findings reveal a previously unrecognized frontline defense strategy that helps pathogens survive immune attack and may represent a new target for antimicrobial therapies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sultana, S., Tawiah, P. O., Jackson, C., Bennis, M., Bhimwal, T., Anane, A., Knoke, L. R., Foti, A., Paz, L., Crompton, M. E., Reichmann, D., Leichert, L. I., Dahl, J.-U.. 2026-03-12. A newly identified detoxification system protects uropathogenic Escherichia coli from reactive chlorine species. https://doi.org/10.64898/2026.03.12.711259

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Prevalent Integration of both Xenotropic and Ecotropic Murine Leukemia Virus in the Human Genome of Xenografts

Humanized mouse models are widely used in medical research to represent human conditions (1, 2), but their fidelity could be compromised by mouse-originated infections. However, their susceptibility to mouse pathogens are rarely questioned (3). Here we screened 1,619 publicly available genomic sequencing runs from patient-derived xenograft (PDX) models for the integration of murine leukemia virus (MLV), a rodent retrovirus exists in the mouse genome as an endogenous retrovirus (4), within the human genome. We discovered substantial enrichment of human-MLV chimeric DNA in approximately 25% of them. Analyzing the human-MLV junctions, we found about 90% of them bearing the unmistakable hallmarks of retroviral integration, including the canonical MLV boundaries and the distinctive 4-bp target site duplications (5, 6). It was also assumed that mouse strains without the highly infectious Bxv1 provirus are safe from MLV contamination in xenografts (7, 8). However, we found many PDX models derived from Bxv1- strains, including the widely used NSG strain, are also contaminated by the supposedly rodent-specific ecotropic MLV (E-MLV). We further confirmed a complete E-MLV integrated into the human genome by both HiFi and sanger sequencing. Our discovery raises concerns that mouse-to-human retroviral transmission and integration is more common and less restrictive than previously appreciated. They support examination of MLV integration as a feature of humanized mouse models with implications on the fidelity of these models in recapitulating human cells and tissues. Our discovery also has underscored the importance of comprehensively inactivation of porcine endogenous retroviruses for the clinical application of xenotransplatation (9, 10).

microbiology↗

Necroptosis is a targetable driver of severe coronavirus pathogenesis

Human-pathogenic coronaviruses differ dramatically in pathogenicity but the underlying mechanisms are incompletely understood. Here, we demonstrate that highly pathogenic coronaviruses trigger necroptosis in the infected cells and lung tissues, whereas necroptosis is not detected in cells infected by seasonal coronavirus. Mechanistically, highly pathogenic coronaviruses produce Z-RNA, activate ZBP1 and initiates necroptotic cell death signaling, triggering necroinflammation and lung injury. In contrast, seasonal coronaviruses produce little to no Z-RNA, and do not activate necroptosis. Importantly, small-molecule inhibition of necroptosis attenuates inflammatory cytokine expression and markedly ameliorates lung damage in mice infected with all three highly pathogenic coronaviruses, independent of virus clearance. Overall, our study identifies necroptosis as a dominant mediator of coronavirus pathogenesis, and positions necroptosis blockade as a new therapeutic target against severe coronavirus diseases.

microbiology↗

POM121 regulates lentiviral nuclear import in a capsid-host factor-dependent manner

Lentiviruses such as human immunodeficiency virus 1 (HIV-1) access the nuclear lumen through the nuclear pore complex (NPC), a process coordinated by the interactions between the viral capsid and nucleoporins (NUPs). Here, using unbiased proteomic screens, we identified several capsid-associated NUPs, including POM121. Depletion of POM121 impaired HIV-1 infection in multiple cell lines and in primary CD4+ T cells, whereas equine infectious anaemia virus (EIAV) infection was enhanced, indicating that POM121 effect is virus-specific. A cytoplasmic carboxy-terminal fragment of POM121, containing its FG-rich region inhibited HIV-1 and a broader range of lentiviruses. Analysis of HIV-1 capsid mutants showed that physical interaction with POM121 does not predict functional dependence, as capsids retaining POM121 binding remained insensitive to its depletion. Strikingly, loss of cyclophilin A (CypA) completely abolished HIV-1 dependence on POM121, whereas depletion of CPSF6 produced only partial rescue, demonstrating that POM121 sensitivity is dictated by the broader network of capsid-host interactions. Finally, POM121 depletion impaired HIV-1 nuclear accumulation and selectively disrupted the nuclear import of other viral and cellular cargo. Together, these findings identify POM121 as a selective regulator of lentiviral nuclear entry whose functional contribution is determined by capsid and host-factor context.

microbiology↗